Investigating Lipid-Modulating Agents for Prevention or Treatment of COVID-19
Sign Up to like & getrecommendations! Published in 2021 at "Journal of the American College of Cardiology"
DOI: 10.1016/j.jacc.2021.08.021
Abstract: Coronavirus disease-2019 (COVID-19) is associated with systemic inflammation, endothelial activation, and multiorgan manifestations. Lipid-modulating agents may be useful in treating patients with COVID-19. These agents may inhibit viral entry by lipid raft disruption or ameliorate… read more here.
Keywords: investigating lipid; modulating agents; covid; lipid modulating ... See more keywords
Effect of ABCG2 c.421 C> A (rs2231142) single nucleotide polymorphisms on the lipid-modulating efficacy of rosuvastatin: a meta-analysis
Sign Up to like & getrecommendations! Published in 2025 at "BMC Cardiovascular Disorders"
DOI: 10.1186/s12872-025-04611-0
Abstract: To systematically evaluate the effect of ABCG2 c.421 C > A (rs2231142) single nucleotide polymorphism (SNP) on the lipid-modulating efficacy of rosuvastatin (RST). Searches were conducted using the Wan Fang database, Web of Science, Embase, PubMed, Cochrane… read more here.
Keywords: meta analysis; 421 rs2231142; analysis; modulating efficacy ... See more keywords